Fortress Biotech, Inc.
FBIO
$1.66
$0.021.22%
NASDAQ
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | 47.42% | -17.53% | 28.99% | -66.15% | -83.92% |
| Total Depreciation and Amortization | 17.55% | -19.65% | 0.00% | -0.08% | 0.08% |
| Total Amortization of Deferred Charges | -22.88% | -48.54% | 24.14% | 19.88% | -22.68% |
| Total Other Non-Cash Items | 50.04% | 61.94% | 44.68% | -89.45% | -73.02% |
| Change in Net Operating Assets | -17.79% | -52.47% | -156.35% | 131.21% | -119.69% |
| Cash from Operations | 35.65% | 8.15% | 13.98% | 27.33% | -108.21% |
| Capital Expenditure | -- | -- | -- | -- | -2,700.00% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -100.00% |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | 96.50% |
| Cash from Investing | -- | -- | -- | -- | -101.26% |
| Total Debt Issued | -85.14% | 573.36% | -- | -- | -- |
| Total Debt Repaid | 0.00% | -- | -- | -- | 100.83% |
| Issuance of Common Stock | -91.63% | -- | -- | 69.71% | 830.33% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | 100.00% | 0.00% | 0.00% | 0.00% |
| Other Financing Activities | 154.07% | -383.34% | -3.88% | -36.26% | 137.13% |
| Cash from Financing | 851.90% | -81.00% | -48.80% | -36.13% | 1,724.51% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 87.89% | -129.08% | -406.35% | -71.32% | 159.59% |